BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32530099)

  • 21. Genetic investigation of XPA gene: high frequency of the c.682C>T mutation in Moroccan XP patients with moderate clinical profile.
    Kindil Z; Senhaji MA; Bakhchane A; Charoute H; Chihab S; Nadifi S; Barakat A
    BMC Res Notes; 2017 Dec; 10(1):704. PubMed ID: 29208038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brazilian XP-E siblings carrying a novel DDB2 variant developed early-onset melanoma: a case report.
    de Souza Timoteo AR; Pinheiro de Almeida IC; Yurchenko AA; de Miranda Henriques SR; de Souza Segundo P; Rajabi F; Nikolaev S; Petta TB
    BMC Med Genomics; 2023 Aug; 16(1):186. PubMed ID: 37573316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene alterations and clinical characteristics of xeroderma pigmentosum group A patients in Japan.
    Nishigori C; Moriwaki S; Takebe H; Tanaka T; Imamura S
    Arch Dermatol; 1994 Feb; 130(2):191-7. PubMed ID: 7905727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic homogeneity of mutational spectrum of group-A xeroderma pigmentosum in Tunisian patients.
    Messaoud O; Ben Rekaya M; Cherif W; Talmoudi F; Boussen H; Mokhtar I; Boubaker S; Amouri A; Abdelhak S; Zghal M
    Int J Dermatol; 2010 May; 49(5):544-8. PubMed ID: 20534089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA-based prenatal diagnosis in a Chinese family with xeroderma pigmentosum group A.
    Yang Y; Ding B; Wang K; Bu D; Tu P; Zhu X
    Br J Dermatol; 2004 Jun; 150(6):1190-3. PubMed ID: 15214909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. c.1643_1644delTG XPC mutation is more frequent in Moroccan patients with xeroderma pigmentosum.
    Senhaji MA; Abidi O; Nadifi S; Benchikhi H; Khadir K; Ben Rekaya M; Eloualid A; Messaoud O; Abdelhak S; Barakat A
    Arch Dermatol Res; 2013 Jan; 305(1):53-57. PubMed ID: 23143338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a novel protein truncating mutation p.Asp98* in XPC associated with xeroderma pigmentosum in a consanguineous Pakistani family.
    Ali MZ; Blatterer J; Khan MA; Schaflinger E; Petek E; Ahmad S; Khan E; Windpassinger C
    Mol Genet Genomic Med; 2020 Feb; 8(2):e1060. PubMed ID: 31923348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole-Exome Sequencing Enables the Diagnosis of Variant-Type Xeroderma Pigmentosum.
    Fang X; Sun Y
    Front Genet; 2019; 10():495. PubMed ID: 31178899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole Exome Sequencing of a Patient with a Milder Phenotype of Xeroderma Pigmentosum Group C.
    Seo JI; Nishigori C; Ahn JJ; Ryu JY; Lee J; Lee MH; Kim SK; Jeong KH
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melanoma and other skin cancers in xeroderma pigmentosum patients and mutation in their cells.
    Takebe H; Nishigori C; Tatsumi K
    J Invest Dermatol; 1989 May; 92(5 Suppl):236S-238S. PubMed ID: 2715657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. XPC gene mutations in families with xeroderma pigmentosum from Pakistan; prevalent founder effect.
    Ijaz A; Basit S; Gul A; Batool L; Hussain A; Afzal S; Ramzan K; Ahmad J; Wali A
    Congenit Anom (Kyoto); 2019 Jan; 59(1):18-21. PubMed ID: 29569758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased risk of internal tumors in DNA repair-deficient xeroderma pigmentosum patients: analysis of four international cohorts.
    Nikolaev S; Yurchenko AA; Sarasin A
    Orphanet J Rare Dis; 2022 Mar; 17(1):104. PubMed ID: 35246173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In silico characterization of a novel pathogenic deletion mutation identified in XPA gene in a Pakistani family with severe xeroderma pigmentosum.
    Nasir M; Ahmad N; Sieber CM; Latif A; Malik SA; Hameed A
    J Biomed Sci; 2013 Sep; 20(1):70. PubMed ID: 24063568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A stop codon in xeroderma pigmentosum group C families in Turkey and Italy: molecular genetic evidence for a common ancestor.
    Gozukara EM; Khan SG; Metin A; Emmert S; Busch DB; Shahlavi T; Coleman DM; Miller M; Chinsomboon N; Stefanini M; Kraemer KH
    J Invest Dermatol; 2001 Aug; 117(2):197-204. PubMed ID: 11511294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistence of repair proteins at unrepaired DNA damage distinguishes diseases with ERCC2 (XPD) mutations: cancer-prone xeroderma pigmentosum vs. non-cancer-prone trichothiodystrophy.
    Boyle J; Ueda T; Oh KS; Imoto K; Tamura D; Jagdeo J; Khan SG; Nadem C; Digiovanna JJ; Kraemer KH
    Hum Mutat; 2008 Oct; 29(10):1194-208. PubMed ID: 18470933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The present status of xeroderma pigmentosum in Japan and a tentative severity classification scale.
    Nakano E; Masaki T; Kanda F; Ono R; Takeuchi S; Moriwaki S; Nishigori C
    Exp Dermatol; 2016 Aug; 25 Suppl 3():28-33. PubMed ID: 27539899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Iberian legacy into a young genetic xeroderma pigmentosum cluster in central Brazil.
    Castro LP; Sahbatou M; Kehdy FSG; Farias AA; Yurchenko AA; de Souza TA; Rosa RCA; Mendes-Junior CT; Borda V; Munford V; Zanardo ÉA; Chehimi SN; Kulikowski LD; Aquino MM; Leal TP; Tarazona-Santos E; Chaibub SC; Gener B; Calmels N; Laugel V; Sarasin A; Menck CFM
    Mutat Res Genet Toxicol Environ Mutagen; 2020 Apr; 852():503164. PubMed ID: 32265042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical profile and mutation analysis of xeroderma pigmentosum in Indian patients.
    Tamhankar PM; Iyer SV; Ravindran S; Gupta N; Kabra M; Nayak C; Kura M; Sanghavi S; Joshi R; Chennuri VS; Khopkar U
    Indian J Dermatol Venereol Leprol; 2015; 81(1):16-22. PubMed ID: 25566891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Xeroderma pigmentosum complementation group G patient with a novel homozygous missense mutation and no neurological abnormalities.
    Moriwaki S; Takigawa M; Igarashi N; Nagai Y; Amano H; Ishikawa O; Khan SG; Kraemer KH
    Exp Dermatol; 2012 Apr; 21(4):304-7. PubMed ID: 22417308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole-exome sequencing enables rapid determination of xeroderma pigmentosum molecular etiology.
    Ortega-Recalde O; Vergara JI; Fonseca DJ; Ríos X; Mosquera H; Bermúdez OM; Medina CL; Vargas CI; Pallares AE; Restrepo CM; Laissue P
    PLoS One; 2014; 8(6):e64692. PubMed ID: 23755135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.